Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check3 days agoChange DetectedThe record history page’s displayed software/application revision was updated from v3.5.2 to v3.5.3, reflecting a site version change without altering the underlying study history content.SummaryDifference0.1%

- Check10 days agoChange DetectedThe record history now shows Revision: v3.5.2 as the latest entry, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.5.0 was added to the Record History page, updating the version shown. The prior revision v3.4.3 is removed from the history listing.SummaryDifference0.1%

- Check47 days agoChange DetectedThe history adds Active, not recruiting status and updates to Contacts/Locations, Study Design, Study Status, and Recruitment Status, along with a new revision entry (v3.4.3) dated 2026-03-06; the prior Recruiting status was removed (2025-10-09, v3.4.2).SummaryDifference0.7%

- Check75 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added. The notice about government funding lapse (Revision: v3.4.1) was removed.SummaryDifference0.6%

- Check82 days agoChange DetectedA new funding notice was added and the page revision was updated to v3.4.1 (replacing v3.4.0); these are administrative updates that do not affect study details.SummaryDifference0.6%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.